What's new

Human medicines European public assessment report (EPAR): MicardisPlus, Date of authorisation: 19/04/2002, Revision: 37, Status: Authorised

Human medicines European public assessment report (EPAR): MicardisPlus, Date of authorisation: 19/04/2002, Revision: 37, Status: Authorised

Mar 31, 2025 - 14:56
 0
Human medicines European public assessment report (EPAR): MicardisPlus, Date of authorisation: 19/04/2002, Revision: 37, Status: Authorised
Human medicines European public assessment report (EPAR): MicardisPlus, Date of authorisation: 19/04/2002, Revision: 37, Status: Authorised
Read More

Tags:

Previous Article

DS 3 review

Next Article

Some Super Cool Electric Bus News In March From East & Southern Africa

Related Posts

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) – July 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 23 July 2025, 10:00 (CEST) to 23 July 2025, 12:00 (CEST)

Meeting of the Executive Steering Group on Shortages an...

Feb 9, 2025  0

Human medicines European public assessment report (EPAR): Rolufta Ellipta (previously Rolufta), umeclidinium, Date of authorisation: 20/03/2017, Revision: 14, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 28, 2025  0

Human medicines European public assessment report (EPAR): Deqsiga, human normal immunoglobulin, Status: Opinion

Human medicines European public assessment report (EPAR...

Feb 28, 2025  0